Dr. Douglas J. Veale of University College Dublin, who was involved in FAST, offered a closing comment.
“I think you would agree that if we thought 10 years ago that we would be sitting in a room this big talking to this many people about any drug trial in systemic sclerosis, we would have been very excited. I think to have two trials showing benefits for patients is a remarkable achievement. The greatest need now is close collaboration from both sides of the Atlantic in designing similar studies with sufficient power,” he said.
“I could not possibly agree more,” Dr. Furst replied.